(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging-Reference-Cited by-同舟云学术

(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging

Published:2020-03-24 Issue:7 Volume:63 Page:3563-3576
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Duan Xiaojiang¹,Liu Futao¹,Kwon Hongmok²,Byun Youngjoo²^ORCID,Minn Il³,Cai Xuekang¹,Zhang Jingming¹,Pomper Martin G.³^ORCID,Yang Zhi⁴^ORCID,Xi Zhen⁵^ORCID,Yang Xing¹⁶^ORCID

Affiliation:

1. Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China

2. College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, Republic of Korea

3. Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, United States

4. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China

5. State Key Laboratory of Elemento-Organic Chemistry and Department of Chemical Biology, National Pesticide Engineering Research Center (Tianjin), Nankai University, Tianjin 300071, China

6. Institute of Medical Technology, Peking University, Beijing 100191. China

Funder

National Research Foundation of Korea

National Natural Science Foundation of China

Clinical Medicine Plus X - Young Scholars Project

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b02031

Reference40 articles.